1. 3-Methyladenine attenuates neuroinflammation and improves cognitive function in sepsis-associated encephalopathy by inhibiting autophagy.
- Author
-
Zhu, Tao, Yao, Yinping, Ding, Junchao, Zhang, Chengyue, Xia, Ningxiao, Tao, Yilin, Zhang, Wenhao, Qi, Hantao, Gong, Lifen, and Jiang, Peifang
- Subjects
- *
BODY temperature , *POLYMERASE chain reaction , *COGNITION disorders , *NEUROGLIA , *INTRAPERITONEAL injections - Abstract
• 3-MA improved the basal physiological status of mice with SAE. • 3-MA relieved symptoms and manifestations of acute encephalopathy. • 3-MA reduced neuroinflammation by suppressing glial cell activation and neuronal damage. • 3-MA alleviated cognitive impairment by inhibiting autophagy. Sepsis-associated encephalopathy (SAE) can lead to severe cerebral dysfunction as well as cognitive dysfunction, resulting in a significant disease burden. 3-Methyladenine (3-MA) has been confirmed to have anti-inflammatory effects on diseases characterized by enhanced autophagy. However, its role in SAE has not been clarified. An SAE mouse model was generated by intraperitoneal injection of lipopolysaccharide (LPS). Mice were given 5, 20, or 80 mg/kg 3-MA to determine the therapeutic dose. The mice in the different groups were given 20 mg/kg 3-MA or saline, and survival, body temperature, body weight and neurobehavioral scores were measured at different time points. The expression of autophagy-related proteins and inflammatory factors was detected by Western blotting, enzyme linked immunosorbent assay (ELISA) and real-time quantitative polymerase chain reaction (RT–qPCR) 12 h after LPS induction. Glial activation and neuronal injury in the hippocampus were detected by immunofluorescence staining and HE staining. The open Field test, novel object recognition (NOR) test, Y-maze test, and Morris water maze (MWM) test were performed to assess cognitive function. Treatment with 20 or 80 mg/kg 3-MA reduced the increase in hippocampal TNF-α, IL-6, and IL-1β expression in SAE model mice, with 20 mg/kg 3-MA having the greatest therapeutic effect. Treatment with 20 mg/kg 3-MA effectively reduced the expression of hippocampal autophagy-related proteins and mortality, ameliorated hypothermia, decreased body weight and electroencephalography (EEG) performance, and attenuated the activation of neuroglia and neuronal damage. Moreover, it alleviated the cognitive dysfunction 2 weeks after LPS induction. 3-MA reduced neuroglial activation and neuronal damage, attenuated neuroinflammation, and improved cognitive deficits during recovery period by inhibiting autophagy in SAE. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF